The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
This protection is driven by its combined ability to lower weight, regulate blood sugar, and reduce systemic inflammation, creating a healthier internal environment for peak performance
Although tirzepatide is not classified as a diuretic, patients may experience changes in fluid balance during treatment, primarily related to weight loss, dietary modifications, and gastrointestinal side effects
Deciding to quit using a substance and reaching a point of resolve is a massive step toward addiction recovery
Lewandowski, Z., Dychaa, E., Pisula-Lewandowska, A
However, this is an important issue for ophthalmologists as we monitor usage of these drugs and how to best be in communication with our patients about them, he said in a statement